학술논문
Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early Stage Classic Hodgkin Lymphoma: Interim Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part C)
Document Type
Abstract
Author
Lee, Hun Ju; Abramson, Jeremy S.; Bartlett, Nancy L. ; Burke, John M.; Lynch, Ryan C. ; Eva, Domingo Domenech ; Hess, Brian T.; Schuster, Steven R. ; Linhares, Yuliya ; Ramchandren, Rod; Gandhi, Mitul; Mowat, Rex ; Shah, Harsh; Rossi, Giuseppe; Hahn, Uwe H ; Prince, Henry Miles ; Ho, Linda; Guo, Wenchuan ; Yasenchak, Christopher A.; Straus, David J.
Source
In Blood 15 November 2022 140 Supplement 1:9399-9401
Subject
Language
ISSN
0006-4971